Product Images Influenza A (h1n1) 2009 Monovalent Vaccine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Influenza A (h1n1) 2009 Monovalent Vaccine NDC 66521-200 by Novartis Vaccines And Diagnostics Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
immediate container label, pre-filled syringe - h1n1 figure 1
carton label, pre-filled syringe - h1n1 figure 2
This is a description of NovazTi's Influenza A (H1N1) monovalent vaccine. It is available in 10x0mL pre-filled single-dose syringes for people aged four and older. The vaccine is manufactured by GSK and distributed by Novartis Vaccines and Diagnostics Inc. The vaccine contains 15ug of influenza hemagglutinin in each 0.5mL dose and is prepared from the embryonic fluid of chicken eggs. The vaccine is not recommended for individuals allergic to egg proteins and contains trace amounts of mercury. Dosage instructions are provided in the enclosed prescribing information. The vaccine should be stored between 2-6°C and kept out of reach of children.*
immediate container label, multidose vial - h1n1 figure 3
NDC 66521-200-10 is a 5mL multidose vial of Influenza A(H1N1) 2009 monovalent vaccine. The vaccine is manufactured by Novartis Vaccines and Diagnostics Limited. It is important to store the vaccine between 2°-8°C (36°-46°F) and not freeze it. The dose is mentioned as 0.5mL and the package circular should be referred to for more information. The manufacturer's US License No. is 1750 and is an affiliate of Novartis Vaccines and Diagnostics Inc. The location of manufacture is Liverpool, England.*
carton label, multidose vial - h1n1 figure 4
This text is a description for Novartis Influenza A (H1N1) 2009 Monovalent Vaccine. The vaccine is stored in a refrigerated container between 2°- 8°C (36" 46°F) and must not be frozen. The package is not to be kept in the reach of children. The vaccine contains small quantities of polymyxin and neomycin, which are not detected in the final product by current assay methods. The vaccine is prepared from the era-embryonic flow of embryonated chicken eggs and should not be used in persons with egg protein allergies. It is recommended to shake the vial well and administer the dosage as per the enclosed prescribing information. The vaccine is manufactured by Novartis Vaccines and Diagnostics Limited in the United Kingdom.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.